InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-43.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Yorke Justin W, Director. Officer active across 1 company, notably Processa Pharmaceuticals, Inc.. Cumulatively, 15 disclosures have been published. Breakdown: 2 buys · 2 sells. Total volume traded: €58k. Activity tracked since 3 December 2021. The latest transaction was filed on 27 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Yorke Justin W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
12,400 shares@ US$0.797510.2% of flowCommon StockSEC:0000897069-25-000153:0
Canonical exit: 27 Apr 2025 (T+90)
8,000 shares@ US$2.69321.4% of flowCommon StockSEC:0000897069-24-000227:0
Canonical exit: 29 Apr 2024 (T+90)
55,267 shares0Common StockSEC:0000897069-23-001674:0
6,000 shares@ US$0.301.8% of flowCommon StockSEC:0000897069-23-001499:0
6,000 shares@ US$0.301.8% of flowCommon StockSEC:0000897069-23-001462:0
12,000 shares@ US$0.212.6% of flowCommon StockSEC:0000897069-23-001440:0
23,636 sharesCommon StockSEC:0000897069-23-001004:0
1,169 sharesCommon StockSEC:0001567619-23-000303:0
18,208 sharesCommon StockSEC:0001567619-23-000329:0
4,393 sharesCommon StockSEC:0001567619-22-015312:0
4,393 sharesCommon StockSEC:0001567619-22-008006:0
1,854 shares@ US$3.308.7% of flowCommon StockSEC:0001567619-22-002079:0
5,500 shares@ US$4.836237.7% of flowCommon StockSEC:0001567619-21-021710:0
1,169 sharesCommon StockSEC:0001567619-21-016570:0
1,169 sharesCommon StockSEC:0001567619-21-014756:0
15 of 15 declarations
About Yorke Justin W
Yorke Justin W is Administrateur and a Director at Processa Pharmaceuticals, Inc. His 15 filings cover the period from 2021-08-09 to 2025-01-31, and among the sampled recent filings, buy amounts total EUR 29332 and sell amounts total EUR 28968. The modal transaction nature is Attribution.
